A multi-center phase II study of nivolumab +/- ipilimumab for patients with metastatic sarcoma (Alliance A091401), results of expansion cohorts
      Google Scholar   
Citation:
J Clin Oncol vol 38 (15_suppl) 11511-11511
Meeting Instance:
ASCO 2020
Year:
2020
Type:
Abstract
Sub type:
Poster Discussion
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Parents:
None
Children:
4215  
Program:
OGC
Primary Committee:
Experimental
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, U24CA196171  
Corr. Author:
 
Authors:
                       
Networks:
COLUMBIA, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-NY016, LAPS-OH007   
Study
Alliance-A091401
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: